Report an error

Spotted something inaccurate in “Apixaban Shows 54% Lower Bleeding Risk Than Rivaroxaban in Clot Treatment”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.